ONLINE
Oct. 27-29, 2021
Dec. 1-3, 2021
#remotehealthcare #ENTcare #remmiehealth
Our main product:
Remmie builds digital remote ENT monitoring solutions offered through Remmie Enterprise and Remmie Consumer products. Remmie Enterprise is composed of Remmie.io, which includes a telemedicine “plug-in” software development kit (SDK) with APIs for Telehealth and a digital ENT monitor (Remmie Dolphin).Remmie Consumer includes the Remmie Dolphin plus the free Remmie smartphone application. The Remmie Dolphin is FDA Class I registered and CE marked, and is the first connected family ENT monitor with integrated close-loop telemedicine that works with any provider platform.The built-in telemedicine connection included within Remmie’s platform allows for virtual live video visits. Remmie Dolphin also enables users at home to collect images, videos, and symptom information and share data with a telemedicine provider through the Remmie app during or preceding remote virtual consultations. Under development is Remmie.ai, which is an AI deep-learning engine for diagnosis assistance for remote ENT care.
Our aim for business and business partners:
[Target department / division]
Corporate development department
[Business development department Type of Companies.]
Providers of virtual health / telemedicine
Telehealth and Telemedicine companies
Medical device manufactures
Medical device distributors
[Principle objective]
To find partners for ;
technical tie-ups, joint venture partners, sales representatives, PoC partners
SWAN Venture Group
GIF Secretariat:
Ms. Lisa Takeshima, Ms. Kana Tatebayashi, Mr. Kentaro Nagao
TEL:06-6944-6400
FAX:06-6944-6293
E-mail:gif@osaka.cci.or.jp